A recent multiplexed image analysis of the immune contexture in hepatocellular cancers in patients treated with neoadjuvant vascular endothelial growth factor and PD-1 inhibition revealed that non-responders and responders had significant differences in the spatial relations of TAMs, lymphocytes, and tumour cells [43]. Here, VEGFA is linked to hepatocellular carcinoma.